Please assess the completion status of the following clinical trial:

Trial Title: Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age from 18-80 years~2. NIHSS ≥ 1~3. Diagnosis of acute ischemic stroke within 72 hours from stroke onset~4. Enrollment into the study within 24 hours after hospital arrival~5. Urine specific gravity level \< 1.030~6. Patient consent~Exclusion Criteria:~1. Patients receiving \> 40 ml/hr IV fluid infusion over 3 hours~2. Acute ischemic stroke caused cardiogenic embolism~3. Urine specific gravity ≥ 1.030~4. Large cerebral infarction area~   1. Infarction \> 1/3 of middle cerebral artery area~  2. Infarction \> 1/2 of cerebellar hemisphere~5. NHISS ≥ 18~6. Previous or current episode of atrial fibrillation~7. Previous or current episode congestive heart failure~8. Previous echocardiogram with ejection fraction \< 40%~9. Previous or current episode of dilated cardiomyopathy~10. Abnormal renal function GFR ≤ 60% or serum creatinine ≥ 2~11. Modified Rankin scale before acute ischemic stroke ≥ 2~12. Patients receiving intravenous thrombolysis~13. NPO with need for IV fluid~14. IV fluid infusion needed from any other causes~15. Patients with poor prognosis with life expectancy \< 90 days~16. Patients involved in other ongoing clinical studies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- IV Fluid (Type: EXPERIMENTAL): 0.9% NaCl solution infusion: 100 ml/hr for three days.
- No IV Fluid (Type: NO_INTERVENTION): Not receive any intravenous fluid but can consume oral fluid normally for three days.

Based on this trial design, predict the completion outcome and termination type (if applicable).